Drug-associated bone resorption with potential dental and implant implications.

Romanos, Georgios E; Vaglica, Michael; Sculean, Anton (2022). Drug-associated bone resorption with potential dental and implant implications. Periodontology 2000, 90(1), pp. 236-246. Wiley 10.1111/prd.12461

[img] Text
Periodontology_2000_-_2022_-_Romanos_-_Drug_associated_bone_resorption_with_potential_dental_and_implant_implications.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB)

Every year more and more innovative pharmacological agents are introduced medicine, to treat systemic diseases. Due to these rapid and recent advancements, many patients are receiving treatment with a high variety of drugs, such as selective serotonin reuptake inhibitors, bisphosphonates, tumor necrosis factor (TNF)-α inhibitors, cyclosporine, and steroids. Since implant and osseous surgery are common treatment modalities used, within dentistry, it is of critical important to acknowledge and discuss the potential effects of selective serotonin reuptake inhibitors, bisphosphonates, TNF-α inhibitors, cyclosporine, and steroids, on bone healing. The present paper discusses the possible detrimental ramifications and risks these drug classes may have on bone healing.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > School of Dental Medicine > Department of Periodontology

UniBE Contributor:

Sculean, Anton

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1600-0757

Publisher:

Wiley

Language:

English

Submitter:

Beatrix Margrit Stalder

Date Deposited:

02 Dec 2022 17:45

Last Modified:

05 Dec 2022 16:27

Publisher DOI:

10.1111/prd.12461

PubMed ID:

35916776

Uncontrolled Keywords:

bone resorption drugs implant complications

BORIS DOI:

10.48350/174287

URI:

https://boris.unibe.ch/id/eprint/174287

Actions (login required)

Edit item Edit item
Provide Feedback